Logo

Swiss Lab Buys Partek's Genomics Lab for Epigenetic, Neurobio Studies

Dec 20, 2006
NEW YORK (GenomeWeb News) — The Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland has bought Partek’s tiling and exon array data-handling software, Partek said yesterday.  
 
Partek said FMI’s Functional Genomics Lab will use its genomics suite software to analyze data from studies of epigenetics, growth control, and neurobiology.
 
Partek, based in St. Louis, Mo., is a genomics software developer specializing in an Affymetrix GeneChip-compatible platform used to identify and quantify data patterns.
 
Partek said its genomics suite handles data from “genomic and proteomic studies, high throughput-screening campaigns, and computer-aided drug design.”
 
Financial terms of the deal were not released.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.